Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.

J Cancer Res Clin Oncol 2010 Mar 16;136(3):387-94. Epub 2009 Sep 16.

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, 120-752, Korea.

Purpose: Small bowel adenocarcinoma (SBA) is a rare malignancy with a poor outcome. We evaluated the natural history of SBA at a single Korean institute.

Methods: Medical records of 100 patients with SBA were reviewed for clinical characteristics, treatment patterns, outcomes, and prognostic factors.

Results: The most common primary tumor site was the duodenum (82%). Seventy-four patients were diagnosed with stage III/IV disease (28/46 patients, respectively). Sixty-six patients had surgery (R0/R1/R2 in 32/2/32) without operation-related mortality. Of 34 R0/R1-resected patients, 16 received adjuvant chemotherapy. The dominant pattern of recurrence following R0/R1 resection was distant metastasis (29%; 10 of 34 patients). Thirty-four patients with advanced SBA received palliative chemotherapy, showing a response rate of 27.6% and a median progression-free survival of 3.8 months. The median overall survival for all patients and R0/R1-resected patients was 10.5 and 42.1 months, respectively. In multivariate analysis, lower stage, nonduodenal location, and R0/R1 resection were good independent prognostic factors.

Conclusions: Early diagnosis is crucial to improve outcomes of SBA with respect to increasing resectability. Distant metastasis as a dominant pattern of recurrence suggests a potential role for adjuvant chemotherapy. Newer antitumor agents in advanced SBA should be evaluated considering the poor efficacy of current palliative chemotherapy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0668-3DOI Listing
March 2010
6 Reads

Publication Analysis

Top Keywords

patients
9
dominant pattern
8
r0/r1-resected patients
8
pattern recurrence
8
distant metastasis
8
palliative chemotherapy
8
advanced sba
8
r0/r1 resection
8
adjuvant chemotherapy
8
single korean
8
small bowel
8
sba
6
421 months
4
patients sixty-six
4
28/46 patients
4
disease 28/46
4
iii/iv disease
4
months multivariate
4
sixty-six patients
4
patients 105
4

References

(Supplied by CrossRef)

S Agrawal et al.
Ann Surg Oncol 2007

G Barnes et al.
Ann Surg Oncol 1994

RL Bauer et al.
Ann Surg Oncol 1994

KY Bilimoria et al.
Ann Surg 2009

WH Chow et al.
Cancer Causes Control 1993

C Crawley et al.
Br J Cancer 1998

BS Dabaja et al.
Cancer 2004

PN Fishman et al.
Am J Clin Oncol 2006

MK Gibson et al.
Oncologist 2005

FL Greene et al.
2002

Similar Publications